Last reviewed · How we verify

Brufen

Ain Shams University · FDA-approved active Small molecule ✓ Verified May 2026

Brufen is a Small molecule drug developed by Ain Shams University. It is currently FDA-approved. Also known as: Advil, Nurfen, ibuprofen 600 mg.

Brufen, also known as ibuprofen, is a small molecule that works as a cyclooxygenase inhibitor to relieve pain, fever, and inflammation. It is used to treat various conditions, including chronic and acute low back pain, chronic pain, and other conditions such as painful menstrual periods, migraines, and rheumatoid arthritis.

At a glance

Generic nameBrufen
Also known asAdvil, Nurfen, ibuprofen 600 mg
SponsorAin Shams University
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Brufen

What is Brufen?

Brufen is a Small molecule drug developed by Ain Shams University.

Who makes Brufen?

Brufen is developed and marketed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).

Is Brufen also known as anything else?

Brufen is also known as Advil, Nurfen, ibuprofen 600 mg.

What development phase is Brufen in?

Brufen is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing